SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001104659-17-067935
Filing Date
2017-11-13
Accepted
2017-11-13 16:05:37
Documents
1
Period of Report
2017-09-30
Effectiveness Date
2017-11-13

Document Format Files

Seq Description Document Type Size
1 10-Q a17-26297_1nt10q.htm NT 10-Q 57210
  Complete submission text file 0001104659-17-067935.txt   58254
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 171195841
SIC: 2836 Biological Products, (No Diagnostic Substances)